Desio, Italy

Rosellina Damiani

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gnosis Spa. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosellina Damiani. Retrieved from https://idiyas.com/inventor/rosellina-damiani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Rosellina Damiani

Introduction

Rosellina Damiani is a prominent inventor based in Desio, Italy. She has made significant strides in the field of medicine, particularly in the treatment of Alzheimer's disease. Her innovative approach combines the use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) to develop effective medicaments.

Latest Patents

Rosellina holds a patent for the "Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzheimer's disease." This patent highlights her commitment to addressing critical health issues through scientific innovation. She has 1 patent to her name, showcasing her contributions to the medical field.

Career Highlights

Throughout her career, Rosellina has worked with Gnosis Spa, a company dedicated to advancing health solutions. Her role at Gnosis Spa has allowed her to collaborate with other talented professionals in the industry, further enhancing her impact on medical research and development.

Collaborations

Rosellina has collaborated with notable colleagues such as Sigfrido Scarpa and Andrea Fuso. These partnerships have fostered a creative environment that encourages the exchange of ideas and innovative solutions.

Conclusion

Rosellina Damiani's work exemplifies the spirit of innovation in the medical field. Her dedication to developing treatments for Alzheimer's disease through her patented methods is a testament to her expertise and commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…